Is TapImmune’s cancer vaccine the real deal?
A small study testing a cancer vaccine by a company who licensed the technology from the Mayo Clinic showed promising results in breast and ovarian cancer.
Mayo Clinic to license vaccine technology to Seattle startup
Mayo Clinic is partnering with a Seattle-based biotech startup to develop vaccines against breast cancer and smallpox, the company said. TapImmune Inc. (OTCBB:TPIV) said it reached a deal to license Mayo technology that will help the company develop a vaccine that it says can prompt the body's immune system to mount an aggressive attack on the diseases.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.